PT87137A - Process for the preparation of an immunogenic polypeptide express by a recombinant yeast - Google Patents

Process for the preparation of an immunogenic polypeptide express by a recombinant yeast

Info

Publication number
PT87137A
PT87137A PT87137A PT8713788A PT87137A PT 87137 A PT87137 A PT 87137A PT 87137 A PT87137 A PT 87137A PT 8713788 A PT8713788 A PT 8713788A PT 87137 A PT87137 A PT 87137A
Authority
PT
Portugal
Prior art keywords
preparation
recombinant yeast
immunogenic polypeptide
polypeptide express
express
Prior art date
Application number
PT87137A
Other languages
English (en)
Other versions
PT87137B (pt
Inventor
Victor Nussenzweig
Philip J Barr
Original Assignee
Univ New York
Chiron Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York, Chiron Corp filed Critical Univ New York
Publication of PT87137A publication Critical patent/PT87137A/pt
Publication of PT87137B publication Critical patent/PT87137B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/002—Protozoa antigens
    • A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT87137A 1987-03-30 1988-03-30 Processo de preparacao do produto de expressao de levedura recombinante PT87137B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3232687A 1987-03-30 1987-03-30

Publications (2)

Publication Number Publication Date
PT87137A true PT87137A (pt) 1988-04-01
PT87137B PT87137B (pt) 1992-07-31

Family

ID=21864341

Family Applications (2)

Application Number Title Priority Date Filing Date
PT87137A PT87137B (pt) 1987-03-30 1988-03-30 Processo de preparacao do produto de expressao de levedura recombinante
PT87332A PT87332B (pt) 1987-03-30 1988-04-26 Metodo de purificacao de produto de expressao de levedura recombinante

Family Applications After (1)

Application Number Title Priority Date Filing Date
PT87332A PT87332B (pt) 1987-03-30 1988-04-26 Metodo de purificacao de produto de expressao de levedura recombinante

Country Status (9)

Country Link
EP (1) EP0309555A4 (pt)
JP (1) JPH01503514A (pt)
AU (1) AU617668B2 (pt)
ES (1) ES2009587A6 (pt)
IL (1) IL85905A0 (pt)
NZ (1) NZ224086A (pt)
PT (2) PT87137B (pt)
WO (1) WO1988007546A1 (pt)
ZA (1) ZA882272B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
SE8904100D0 (sv) * 1989-12-05 1989-12-05 Astra Ab New analysis method
NZ233255A (en) * 1989-04-11 1993-02-25 Chiron Corp Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope
US5095093A (en) * 1990-11-06 1992-03-10 The United States Of America As Represented By The Secretary Of The Navy Protective four amino acid epitope against Plasmodium vivax malaria
WO1993011157A1 (en) * 1991-11-27 1993-06-10 The Council Of The Queensland Institute Of Medical Research MALARIAL VACCINE AND PEPTIDES COMPRISING HUMAN T-CELL EPITOPE OF CIRCUMSPOROZOITE PROTEIN OF $i(P.VIVAX)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4707357A (en) * 1984-06-26 1987-11-17 The United States Of America As Represented By The Secretary Of The Army Immunologically active peptides capable of inducing immunization against malaria and genes encoding therefor
NZ213303A (en) * 1984-09-12 1988-09-29 Univ New York Plasmodium protein, dna sequence and vaccine
US4826957A (en) * 1985-07-12 1989-05-02 New York University Immunogenic recombinant yeast expression product and method for purifying it
ATE118784T1 (de) * 1985-07-12 1995-03-15 Univ New York Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
US4693994A (en) * 1985-11-19 1987-09-15 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Protective synthetic peptide against malaria and encoding gene
EP0252588A3 (en) * 1986-05-12 1989-07-12 Smithkline Beecham Corporation Process for the isolation and purification of p. falciparum cs protein expressed in recombinant e. coli, and its use as a vaccine

Also Published As

Publication number Publication date
NZ224086A (en) 1991-02-26
AU617668B2 (en) 1991-12-05
JPH01503514A (ja) 1989-11-30
WO1988007546A1 (en) 1988-10-06
PT87332B (pt) 1992-07-31
EP0309555A4 (en) 1990-04-10
AU1593688A (en) 1988-11-02
ES2009587A6 (es) 1989-10-01
PT87137B (pt) 1992-07-31
ZA882272B (en) 1988-09-22
PT87332A (pt) 1988-05-01
EP0309555A1 (en) 1989-04-05
IL85905A0 (en) 1988-09-30

Similar Documents

Publication Publication Date Title
PT86318A (en) Process for the preparation of immunogenic proteins
HUT52963A (en) Process for production of recombinant coccidiose vaccines
AU7831787A (en) Improved recombinant expression
PT86600A (pt) Process for the preparation of anticoagulant peptides
AU1482488A (en) Leader sequences for the production of recombinant proteins
AU1628895A (en) Recombinant virus
PT85849A (en) Process for the preparation of novel lymphokine related peptides
DK518988A (da) Vanduoploeseligt polypeptidpraeparat
HK153395A (en) Processor for the production of hcmv glycoproteins,antibodies thereto and hcmv vaccines and recombinant vectors therefor
HU890720D0 (en) Process for the preparation of protein-like water-dispersingable macrocolloides
AU5941486A (en) Tetanus vaccine from cloned antigen
IL82935A0 (en) Secretion of heterologous proteins from yeast
PT86091A (en) Process for the preparation of novel peptides
DK665688D0 (da) Polypeptid
PT85461A (en) Process for preparing recombinant htlv-iii proteins and uses thereof
PT87137A (pt) Process for the preparation of an immunogenic polypeptide express by a recombinant yeast
PT87857A (pt) Process for the preparation of novel immunossupressant peptides
HUT39362A (en) Process for preparing polypeptide vaccine
IT7950629A0 (it) Procedimento per la preparazione di ossido di zirconio a partire da zirconato di calcio tecnico
AU2684388A (en) Peptides acting to influence the mammalian pituitary
PT87207A (pt) Process for preparing recombinant htlv-iii proteins and uses thereof
AU1563188A (en) A process for the preparation of a genetically encodable polypeptide
AU6385886A (en) Production of ige-binding protein by recombinant methods
PT85033A (en) Process for the preparation of novel peptides
PT86162A (en) Recombinant protein expression

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19920110